Worse Renal Function is Associated with Markedly Worse Outcomes Among STEMI Patients Undergoing Primary PCI: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction ( APEX AMI) Trial
Publication
, Journal Article
Vavalle, JP; van Diepen, S; Lopes, R; Clare, R; Hochman, JS; Weaver, D; Mehta, R; Pieper, KS; Patel, MR; Armstrong, PW; Granger, CB
Published in: CIRCULATION
November 20, 2012
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 20, 2012
Volume
126
Issue
21
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Vavalle, J. P., van Diepen, S., Lopes, R., Clare, R., Hochman, J. S., Weaver, D., … Granger, C. B. (2012). Worse Renal Function is Associated with Markedly Worse Outcomes Among STEMI Patients Undergoing Primary PCI: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction ( APEX AMI) Trial. CIRCULATION, 126(21).
Vavalle, John P., Sean van Diepen, Renato Lopes, Robert Clare, Judith S. Hochman, Douglas Weaver, Rajendra Mehta, et al. “Worse Renal Function is Associated with Markedly Worse Outcomes Among STEMI Patients Undergoing Primary PCI: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction ( APEX AMI) Trial.” CIRCULATION 126, no. 21 (November 20, 2012).
Vavalle JP, van Diepen S, Lopes R, Clare R, Hochman JS, Weaver D, et al. Worse Renal Function is Associated with Markedly Worse Outcomes Among STEMI Patients Undergoing Primary PCI: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction ( APEX AMI) Trial. CIRCULATION. 2012 Nov 20;126(21).
Vavalle, John P., et al. “Worse Renal Function is Associated with Markedly Worse Outcomes Among STEMI Patients Undergoing Primary PCI: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction ( APEX AMI) Trial.” CIRCULATION, vol. 126, no. 21, LIPPINCOTT WILLIAMS & WILKINS, Nov. 2012.
Vavalle JP, van Diepen S, Lopes R, Clare R, Hochman JS, Weaver D, Mehta R, Pieper KS, Patel MR, Armstrong PW, Granger CB. Worse Renal Function is Associated with Markedly Worse Outcomes Among STEMI Patients Undergoing Primary PCI: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction ( APEX AMI) Trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2012 Nov 20;126(21).
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 20, 2012
Volume
126
Issue
21
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology